19 Apr, 2024 08:41 AM
INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce the successful completion of an analytical validation study for its blood test for ovarian cancer. Overall, the test correctly identified 85...read more
15 Apr, 2024 01:14 PM
INOVIQ Ltd (ASX:IIQ) (INOVIQ) and Promega Corporation (Promega) are partnering to unlock the commercial potential of exosomes for research, diagnostic and therapeutic applications. This agreement wi...read more
22 Feb, 2024 02:42 PM
INOVIQ Limited (ASX:IIQ or INOVIQ) is excited to announce the successful completion of its breast cancer study.
In a 2023 clinical validation study (n=483), INOVIQ’s SubB2M/CA15-3 test dete...read more
22 Feb, 2024 12:20 PM
Description
The securities of INOVIQ Ltd (‘IIQ’) will be placed in trading halt at the request of IIQ, pending it releasing an announcement. Unless ASX decides otherwise, the sec...read more
31 Jan, 2024 10:32 AM
“Those who know me from my role as Chairman of PolyNovo (ASX: PNV), know how excited I am to lead a company dedicated to saving lives and improving patient outcomes. We all have family and fri...read more
08 Nov, 2023 10:30 AM
Melbourne, Australia, 8 November 2023: INOVIQ Limited (ASX:IIQ) today advises that it will present new data on the effectiveness and utility of its proprietary exosome isolation technology, EXO-NET&...read more